knowledge -WSS

knowledge

author：focus 2025-10-02 05:01:21 - browse：1633

A sign of Elevance Health behind some flowers — coverage from STAT — Michael Conroy/AP

These days, the surefire way to get ahead in health insurance is to become a health care provider, and Elevance just upped the ante. It’s joining with private equity to launch a $4 billion primary care company.

Elevance leaders divulged more about the company’s venture with Clayton, Dubilier & Rice on its first quarter earnings call Thursday. The partners announced the new company, yet unnamed, earlier this week, but the release was light on detail. The strategic partnership will house Elevance and CD&R’s doctors, clinics, and the technologies that help those doctors manage their patients.

Health insurers specialize in managing medical costs, and through ventures like this, they apply that expertise to managing patients’ chronic medical conditions. In arrangements like Medicare Advantage, where insurers are paid set amounts for members’ care, they’re incentivized to keep those patients healthy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Drug firms test therapies to halt Alzheimer’s before symptoms arise

WSS

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Medicare explains how it will choose drugs for negotiation

WHO may add ‘noma' to its list of neglected tropical diseases

Why Sanofi got shellacked over its spinoff

FDA panel gives mixed vote on blood pressure devices

entertainment

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

focus

State Dept. review finds Biden bears some blame for Afghanistan failures

Why more medical students aren't specializing in primary care

Medical records are filled with copy

Medicare explains how it will choose drugs for negotiation

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Psilocybin's anti

Sports medicine is finally prioritizing gender equality

CDC recommends rationing of RSV shot due to shortages

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

How Long Island became the ‘eugenics capital of the world’

Wikipedia

FDA panel gives mixed vote on blood pressure devices

Medtronic CEO on promising devices for diabetes, hypertension

NYU Langone launches private ChatGPT for its health care data

The pink breast cancer awareness ribbon needs a redesign

Australia’s approach to dialysis celebrates life

Emergency medicine has repudiated 'excited delirium.' Now what?

hotspot

hotspot

explore

hotspot